 Source: CI Photos Shutterstock.com Plus Therapeutics NASDAQ: PSTV stock is in the news Thursday as investors react to the company getting a 17.6 million grant. That Product Development Research grant comes from the Cancer Prevention and Research Institute of Texas. 